1. Home
  2. ALLK vs COCH Comparison

ALLK vs COCH Comparison

Compare ALLK & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • COCH
  • Stock Information
  • Founded
  • ALLK 2012
  • COCH 1995
  • Country
  • ALLK United States
  • COCH United States
  • Employees
  • ALLK N/A
  • COCH N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • COCH Blank Checks
  • Sector
  • ALLK Health Care
  • COCH Finance
  • Exchange
  • ALLK Nasdaq
  • COCH Nasdaq
  • Market Cap
  • ALLK 58.0M
  • COCH 64.4M
  • IPO Year
  • ALLK 2018
  • COCH N/A
  • Fundamental
  • Price
  • ALLK $1.16
  • COCH $2.14
  • Analyst Decision
  • ALLK Hold
  • COCH Strong Buy
  • Analyst Count
  • ALLK 5
  • COCH 4
  • Target Price
  • ALLK $1.67
  • COCH $7.92
  • AVG Volume (30 Days)
  • ALLK 1.3M
  • COCH 674.0K
  • Earning Date
  • ALLK 11-06-2024
  • COCH 11-14-2024
  • Dividend Yield
  • ALLK N/A
  • COCH N/A
  • EPS Growth
  • ALLK N/A
  • COCH N/A
  • EPS
  • ALLK N/A
  • COCH N/A
  • Revenue
  • ALLK N/A
  • COCH $278,000.00
  • Revenue This Year
  • ALLK N/A
  • COCH N/A
  • Revenue Next Year
  • ALLK N/A
  • COCH $17.09
  • P/E Ratio
  • ALLK N/A
  • COCH N/A
  • Revenue Growth
  • ALLK N/A
  • COCH 15.35
  • 52 Week Low
  • ALLK $0.54
  • COCH $0.75
  • 52 Week High
  • ALLK $3.41
  • COCH $11.46
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 51.18
  • COCH 40.46
  • Support Level
  • ALLK $1.29
  • COCH $1.88
  • Resistance Level
  • ALLK $1.56
  • COCH $2.28
  • Average True Range (ATR)
  • ALLK 0.14
  • COCH 0.30
  • MACD
  • ALLK -0.03
  • COCH -0.00
  • Stochastic Oscillator
  • ALLK 14.89
  • COCH 30.66

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

Share on Social Networks: